Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand

2019 ◽  
Vol 37 (10) ◽  
pp. 1277-1286 ◽  
Author(s):  
Khachen Kongpakwattana ◽  
Zanfina Ademi ◽  
Thanaputt Chaiyasothi ◽  
Surakit Nathisuwan ◽  
Ella Zomer ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
Disease Prevention ◽  
Cost Effectiveness Analysis ◽  
Cardiovascular Disease Prevention ◽  
Effectiveness Analysis ◽  
Lipid Modifying Agents

scholarly journals Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0155699 ◽  
Author(s):  
Thi-Phuong-Lan Nguyen ◽  
E. Pamela Wright ◽  
Thanh-Trung Nguyen ◽  
C. C. M. Schuiling-Veninga ◽  
M. J. Bijlsma ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
Disease Prevention ◽  
Cost Effectiveness Analysis ◽  
Cardiovascular Disease Prevention ◽  
Effectiveness Analysis

Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease

2013 ◽  
Vol 17 (2) ◽  
pp. 132-141
Author(s):  
Evangelos Hytopoulos ◽  
Martin L. Lee ◽  
Michael Beggs ◽  
Cynthia French ◽  
Kuo Bianchini Tong
Keyword(s):  
Cardiovascular Disease ◽  
Risk Assessment ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Next Generation ◽  
Assessment Score ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document